in pictures and a few words
What it is and why it matters
Zuranolone is a tablet for the depression that can come after childbirth. It is taken for two weeks and then stopped.
- The first tablet approved in the US specifically for depression after childbirth
- It works differently from the usual depression tablets
What changes after childbirth
During pregnancy the body has plenty of a calming substance. It is made from a pregnancy hormone and helps the brain damp down excess excitement.
- Over the months of pregnancy the brain gets used to this substance
- After birth its level drops within a matter of hours
- In some the brain lags behind: one of the causes of depression, with sleep loss and strain
How the tablet works
The tablet acts like that same calming substance. It doesn’t rebuild the brain — it gives back the missing piece.
- The brain again has something to damp down excess excitement with
- The usual depression tablets work through a different brain system
Helps in days, not weeks
The usual depression tablets need weeks. Here a difference from tablets without the medicine was seen as early as the third day.
- For a mother with a newborn, waiting several weeks is a very long time
- Depression at this time hits both the bond with the baby and the whole family
Tested in people. Tested in people: in women with depression after childbirth, the difference appeared as early as the third day.
Depression eases
In two studies, women with depression after childbirth had fewer signs of it than those who took tablets without the medicine.
- Noticeable improvement came more often
- More often the signs of depression nearly went away
- The benefit held after the course — to the end of follow-up, about a month and a half in
Tested in people. Tested in people: in two studies of women who had depression after childbirth.
A course of just two weeks
The tablets are taken for 14 days and then stopped. This is not months of treatment, as with the usual depression tablets.
- The aim is to support the brain while it is most off balance after birth
- And to give it time to readjust on its own
At home, not in hospital
A similar medicine was given by drip for about 60 hours straight, in hospital. This tablet is taken at home.
- For a mother with a newborn, that is a big difference
How to take it
The capsules are taken in the evening, with a fatty meal, for 14 days. In the evening — so that the strongest sleepiness falls at night.
- During the course a doctor checks how you are feeling
- The medicine is dispensed under special rules — a doctor prescribes it
Important. Do not drive for at least 12 hours after a dose: a person may not notice how much the sleepiness is affecting them.
Who should see a doctor first
Sleepiness and dizziness are the most common effects. So everything important is discussed with a doctor before the course starts.
- You need a helper for two weeks for night care of the baby: on your own it isn’t safe
- If you breastfeed, the decision is made together with your doctor
- The tablet is for depression after childbirth; it doesn’t suit ordinary depression
Important. Severe depression after childbirth with thoughts of suicide needs immediate help, not waiting for the tablet to work.
In one sentence
The tablet gives the brain back a calming substance that ran low after childbirth and helps within days. The course is two weeks, in the evening, no driving and with a helper close by.
Key points
Zuranolone (Zurzuvae) is a tablet for postpartum depression that replaces the neurosteroid that collapsed after birth; the course is 14 days.
| Situation | How it helps | What human studies showed |
|---|---|---|
| Postpartum depression | replaces the allopregnanolone that collapsed after birth | SKYLARK (Am J Psychiatry, 2023), 196 patients: by day 15 the HAM-D score had fallen by 15.6 points versus 11.6 on placebo (difference −4.0; 95% CI −6.3 to −1.7) [1]; ROBIN (JAMA Psychiatry, 2021), 153 patients: by day 15, −17.8 versus −13.6 points (difference −4.2; p=0.003) [2] |
| Fast effect | days rather than the weeks antidepressants need | separation from placebo as early as day 3 [1, 2] |
| Response and remission | more often than on placebo | the odds of response rose roughly 2.6-fold and of remission about 2.5-fold [2] |
| After the course ends | a course of just 14 days | separation held at days 28 and 45 [1] and from day 3 through day 45 [2] |
| Treatment at home | a tablet at home instead of a brexanolone infusion of roughly 60 hours in hospital | — |
How it helps
What collapses after birth
Progesterone has a metabolite: allopregnanolone. It is a neurosteroid — a substance produced partly in the brain itself and acting directly on how the brain works. Its job is to strengthen GABA, the main inhibitory system of the nervous system. In plain terms, it turns excitation down.
Through pregnancy its level rises many-fold, and the brain gradually adjusts to that high background: receptor sensitivity shifts and the system settles into a new equilibrium.
After birth the level falls within hours. In most women the receptors readjust. In some they do not, and the inhibitory system is left destabilised. That is the biological trigger of postpartum depression — on top of sleeplessness, workload and everything else a newborn brings.
Why it works in days
Standard antidepressants work through the serotonin system. They do not replace a deficit directly; they change the conditions the brain then adapts to over weeks. Hence the familiar two to four weeks before an effect appears.
For a woman with a newborn that is a very long time. Depression in this period does not strike her alone: bonding with the child suffers, and so does the whole family.
Zuranolone is built on a different logic: return the missing piece rather than retune the system. It reproduces the action of allopregnanolone, strengthening GABA receptors — including the extrasynaptic ones that set overall inhibitory tone.
| Antidepressants (SSRIs) | Zuranolone | |
|---|---|---|
| Target | Serotonin system | GABA receptors via a neurosteroid |
| Time to effect | Weeks | Days (separation from day 3) |
| Duration of dosing | Months | 14 days |
| Indication in postpartum depression | Yes (general) | Yes (specific) |
How to take it
| Parameter | Detail |
|---|---|
| Formulation | Capsules |
| When | In the evening, with a fatty meal |
| Course | 14 days, then stop |
| Driving | Prohibited for at least 12 hours after a dose |
| Status | Controlled substance |
| Follow-up | Clinical assessment during the course |
Evening dosing is not a convention but a way of placing the peak of sedation inside the night.
Who should see a doctor first
What to know beforehand
▸Sedation. Somnolence and dizziness are the most frequent effects. The boxed warning says it plainly: the ability to drive is impaired, and the woman may not realise how much. ▸Care of the baby. Across the two weeks someone must be available to take night care. This is agreed before starting, not improvised along the way. ▸Breastfeeding. Data on passage into milk exist but are limited; the decision is individual. ▸Controlled substance. Hence the specific prescribing and dispensing arrangements.
Who it is not for
▸Women with depression outside the postpartum period, under the current indication. ▸Anyone who will be alone with the baby for two weeks: sedation makes that unsafe. ▸Anyone counting on driving as usual. ▸As a substitute for monitoring: severe postpartum depression with suicidal thoughts needs immediate help, not a wait for a tablet to work.
Bottom line
▸A physiological mechanism: the drug reproduces the allopregnanolone that collapsed after birth and, through GABA, gives the inhibitory system its footing back. ▸Speed: separation from placebo is visible from the third day, not after a month. ▸A 14-day course, not months of dosing; in the trials the effect held to day 45. ▸The indication is postpartum depression; during the course, no driving and a helper close by.
The condition can be discussed at a consultation; the drug can be ordered here.
References
1. Deligiannidis KM, et al. Zuranolone for the Treatment of Postpartum Depression. Am J Psychiatry. 2023;180(9):668–675. PMID 37491938
2. Deligiannidis KM, et al. Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(9):951–959. PMID 34190962
3. Deligiannidis KM, et al. Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals: Results From a Phase 1 Open-Label Study. J Clin Psychopharmacol. 2024;44(4):337–344. PMID 38739007
4. ZURZUVAE (zuranolone) — US Prescribing Information, Sage Therapeutics and Biogen.
Caveats
Note the placebo arms: −11.6 and −13.6 points. That is a lot. In depression the placebo effect and natural improvement are always large, so the drug's own figure means nothing on its own — only the difference counts, and it came to about 4 points.
What cannot be claimed yet:
▸That it works in depression outside the postpartum period — that application was declined by the FDA, which judged the evidence insufficient. ▸That it is better than antidepressants: no head-to-head trials against SSRIs have been run, only indirect comparisons, which do not substitute for that conclusion. ▸What happens after day 45 — the trials did not follow patients that far. ▸That it replaces therapy and support: the drug takes the edge off, but it solves neither sleeplessness, nor isolation, nor the absence of help at home.
This material is for information only and does not replace a consultation with a doctor.
Key facts
- Zuranolone (brand name Zurzuvae, Sage Therapeutics and Biogen) is the first tablet approved by the FDA specifically for postpartum depression; approval came in August 2023.
- The mechanism differs fundamentally from antidepressants: zuranolone does not act on serotonin but mimics allopregnanolone, a neurosteroid that strengthens the inhibitory GABA system.
- SKYLARK (Am J Psychiatry, 2023): 196 patients; by day 15 the HAM-D depression score had fallen by 15.6 points versus 11.6 on placebo (difference −4.0; 95% CI −6.3 to −1.7), with separation visible as early as day 3.
- ROBIN (JAMA Psychiatry, 2021): 153 patients; by day 15, −17.8 versus −13.6 points (difference −4.2; p=0.003), with the effect holding to day 45.
- The course lasts just 14 days: taken in the evening with a fatty meal, then stopped; because of sleepiness (a boxed warning on the label) driving is prohibited for at least 12 hours after a dose, and someone who can help with the baby needs to be on hand.
